We specialize in: (1) International Business Development to include Europe, North America, Japan & China; (2) Strategic/Corporate Alliances; (3) Capital Access to Venture Capital or Private Equity Funds; and (4) Strategic Advice and M&A.
If you require rapid access to the international therapeutic antibody and proteomics industries, BioForesight has an up-to-date and extensive network of high-level relationships with approximately 300 antibody and proteomics companies worldwide, as well as with venture investors focused on these fields.
BioForesight has the vision and drive to ensure your future success in the most expansive areas of biotechnology & biopharmaceuticals.
